OnonetinTRPM3 blocker CAS# 487-49-0 |
- MK-2894
Catalog No.:BCC1757
CAS No.:1006036-87-8
- MK-2894 sodium salt
Catalog No.:BCC1758
CAS No.:1006036-88-9
- Metformin HCl
Catalog No.:BCC4799
CAS No.:1115-70-4
- Resveratrol
Catalog No.:BCN5607
CAS No.:501-36-0
- 4'-Demethylepipodophyllotoxin
Catalog No.:BCN5918
CAS No.:6559-91-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 487-49-0 | SDF | Download SDF |
PubChem ID | 259632 | Appearance | Powder |
Formula | C15H14O4 | M.Wt | 258.27 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol | ||
Chemical Name | 1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone | ||
SMILES | COC1=CC=C(C=C1)CC(=O)C2=C(C=C(C=C2)O)O | ||
Standard InChIKey | XHBZOAYMBBUURD-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H14O4/c1-19-12-5-2-10(3-6-12)8-14(17)13-7-4-11(16)9-15(13)18/h2-7,9,16,18H,8H2,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Naturally occurring deoxybenzoin. TRPM3 channel blocker (IC50 = 300 nM). Inhibits pregnenolone sulfate-induced intracellular Ca2+ accumulation in HEKmTRPM3 cells and dorsal root ganglia (DRG) neurons in vitro. |
Ononetin Dilution Calculator
Ononetin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.8719 mL | 19.3596 mL | 38.7192 mL | 77.4383 mL | 96.7979 mL |
5 mM | 0.7744 mL | 3.8719 mL | 7.7438 mL | 15.4877 mL | 19.3596 mL |
10 mM | 0.3872 mL | 1.936 mL | 3.8719 mL | 7.7438 mL | 9.6798 mL |
50 mM | 0.0774 mL | 0.3872 mL | 0.7744 mL | 1.5488 mL | 1.936 mL |
100 mM | 0.0387 mL | 0.1936 mL | 0.3872 mL | 0.7744 mL | 0.968 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Phillyrin
Catalog No.:BCN1096
CAS No.:487-41-2
- Phillygenin
Catalog No.:BCN2653
CAS No.:487-39-8
- Pinoresinol
Catalog No.:BCN5591
CAS No.:487-36-5
- Syringaresinol
Catalog No.:BCN3042
CAS No.:487-35-4
- Scopoline
Catalog No.:BCN1942
CAS No.:487-27-4
- Elemicin
Catalog No.:BCN2818
CAS No.:487-11-6
- Citropten
Catalog No.:BCN4831
CAS No.:487-06-9
- Cyclocalopin A
Catalog No.:BCN5587
CAS No.:486430-94-8
- O-Acetylcyclocalopin A
Catalog No.:BCN5586
CAS No.:486430-93-7
- CIQ
Catalog No.:BCC7862
CAS No.:486427-17-2
- AZD2858
Catalog No.:BCC4509
CAS No.:486424-20-8
- Thermopsine
Catalog No.:BCN2603
CAS No.:486-90-8
- Butein
Catalog No.:BCN5592
CAS No.:487-52-5
- Hypaphorine
Catalog No.:BCN2775
CAS No.:487-58-1
- Kainic acid
Catalog No.:BCC6572
CAS No.:487-79-6
- Lindelofine
Catalog No.:BCN2043
CAS No.:487-99-0
- HI TOPK 032
Catalog No.:BCC6225
CAS No.:487020-03-1
- AR-A014418
Catalog No.:BCC1366
CAS No.:487021-52-3
- SNAP 94847 hydrochloride
Catalog No.:BCC7658
CAS No.:487051-12-7
- Curcumol
Catalog No.:BCN5976
CAS No.:4871-97-0
- Heleurine
Catalog No.:BCN1953
CAS No.:488-00-6
- Thesinine
Catalog No.:BCN1990
CAS No.:488-02-8
- 3-Methylcatechol
Catalog No.:BCN3925
CAS No.:488-17-5
- Allitol
Catalog No.:BCN5593
CAS No.:488-44-8
Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.[Pubmed:30134818]
Mol Med. 2018 Aug 14;24(1):44.
BACKGROUND: Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME) is a debilitating disorder that is accompanied by reduced cytotoxic activity in natural killer (NK) cells. NK cells are an essential innate immune cell, responsible for recognising and inducing apoptosis of tumour and virus infected cells. Calcium is an essential component in mediating this cellular function. Transient Receptor Potential Melastatin 3 (TRPM3) cation channels have an important regulatory role in mediating calcium influx to help maintain cellular homeostasis. Several single nucleotide polymorphisms have been reported in TRPM3 genes from isolated peripheral blood mononuclear cells, NK and B cells in patients with CFS/ME and have been proposed to correlate with illness presentation. Moreover, a significant reduction in both TRPM3 surface expression and intracellular calcium mobilisation in NK cells has been found in CFS/ME patients compared with healthy controls. Despite the functional importance of TRPM3, little is known about the ion channel function in NK cells and the epiphenomenon of CFS/ME. The objective of the present study was to characterise the TRPM3 ion channel function in NK cells from CFS/ME patients in comparison with healthy controls using whole cell patch-clamp techniques. METHODS: NK cells were isolated from 12 age- and sex-matched healthy controls and CFS patients. Whole cell electrophysiology recording has been used to assess TRPM3 ion channel activity after modulation with pregnenolone sulfate and Ononetin. RESULTS: We report a significant reduction in amplitude of TRPM3 current after pregnenolone sulfate stimulation in isolated NK cells from CFS/ME patients compared with healthy controls. In addition, we found pregnenolone sulfate-evoked ionic currents through TRPM3 channels were significantly modulated by Ononetin in isolated NK cells from healthy controls compared with CFS/ME patients. CONCLUSIONS: TRPM3 activity is impaired in CFS/ME patients suggesting changes in intracellular Ca(2+) concentration, which may impact NK cellular functions. This investigation further helps to understand the intracellular-mediated roles in NK cells and confirm the potential role of TRPM3 ion channels in the aetiology and pathomechanism of CFS/ME.
Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells.[Pubmed:25595364]
J Dent Res. 2015 Mar;94(3):473-81.
Bone remodeling occurs in response to various types of mechanical stress. The periodontal ligament (PDL) plays an important role in mechanical stress-mediated alveolar bone remodeling. However, the underlying mechanism at the cellular level has not been extensively studied. In this study, we investigated the effect of shear stress on the expression of bone remodeling factors, including receptor activator of nuclear factor-kappa B (NF-kappaB) ligand (RANKL) and osteoprotegerin (OPG), as well as its upstream signaling pathway in primary human PDL cells. We applied hypotonic stress to reproduce shear stress to PDL cells. Hypotonic stress induced the messenger RNA (mRNA) and protein expression of RANKL but not OPG. It also increased intracellular Ca(2+) concentration ([Ca(2+)]i). Extracellular Ca(2+) depletion and nonspecific plasma membrane Ca(2+) channel blockers completely inhibited the increase in both [Ca(2+)]i and RANKL mRNA expression. We identified the expression and activation of transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) channels in PDL cells. Pregnenolone sulfate (PS) and 4alpha-phorbol 12, 13-didecanoate (4alpha-PDD), which are agonists of TRPM3 and TRPV4, augmented Ca(2+) influx and RANKL mRNA expression. Both pharmacological (2-aminoethoxydiphenyl borate [2-APB], ruthenium red [RR], Ononetin [Ono], and HC 067047 [HC]) and genetic (small interfering RNA [siRNA]) inhibitors of TRPM3 and TRPV4 reduced the hypotonic stress-mediated increase in [Ca(2+)]i and RANKL mRNA expression. Our study shows that hypotonic stress induced RANKL mRNA expression via TRPM3- and TRPV4-mediated extracellular Ca(2+) influx and RANKL expression. This signaling pathway in PDL cells may play a critical role in mechanical stress-mediated alveolar bone remodeling.
Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.[Pubmed:24006495]
Mol Pharmacol. 2013 Nov;84(5):736-50.
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable nonselective cation channel that is expressed in a subset of dorsal root (DRG) and trigeminal ganglia sensory neurons. TRPM3 can be activated by the neurosteroid pregnenolone sulfate (PregS) and heat. TRPM3(-)/(-) mice display an impaired sensation of noxious heat and thermal hyperalgesia. We have previously shown that TRPM3 is blocked by the citrus fruit flavanones hesperetin, naringenin, and eriodictyol as well as by Ononetin, a deoxybenzoin from Ononis spinosa. To further improve the tolerability, potency, and selectivity of TRPM3 blockers, we conducted a hit optimization procedure by rescreening a focused library that was composed of chemically related compounds. Within newly identified TRPM3 blockers, isosakuranetin and liquiritigenin displayed favorable properties with respect to their inhibitory potency and a selective mode of action. Isosakuranetin, a flavanone whose glycoside is contained in blood oranges and grapefruits, displayed an IC(5)(0) of 50 nM and is to our knowledge the most potent inhibitor of TRPM3 identified so far. Both compounds exhibited a marked specificity for TRPM3 compared with other sensory TRP channels, and blocked PregS-induced intracellular free Ca(2)(+) concentration signals and ionic currents in freshly isolated DRG neurons. Furthermore, isosakuranetin and previously identified hesperetin significantly reduced the sensitivity of mice to noxious heat and PregS-induced chemical pain. Because the physiologic functions of TRPM3 channels are still poorly defined, the development and validation of potent and selective blockers is expected to contribute to clarifying the role of TRPM3 in vivo.
Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3.[Pubmed:23190005]
Br J Pharmacol. 2013 Apr;168(8):1835-50.
BACKGROUND AND PURPOSE: The melastatin-related transient receptor potential TRPM3 is a calcium-permeable nonselective cation channel that can be activated by the neurosteroid pregnenolone sulphate (PregS) and heat. TRPM3-deficient mice show an impaired perception of noxious heat. Hence, drugs inhibiting TRPM3 possibly get in focus of analgesic therapy. EXPERIMENTAL APPROACH: Fluorometric methods were used to identify novel TRPM3-blocking compounds and to characterize their potency and selectivity to block TRPM3 but not other sensory TRP channels. Biophysical properties of the block were assessed using electrophysiological methods. Single cell calcium measurements confirmed the block of endogenously expressed TRPM3 channels in rat and mouse dorsal root ganglion (DRG) neurones. KEY RESULTS: By screening a compound library, we identified three natural compounds as potent blockers of TRPM3. Naringenin and hesperetin belong to the citrus fruit flavanones, and Ononetin is a deoxybenzoin. Eriodictyol, a metabolite of naringenin and hesperetin, was still biologically active as a TRPM3 blocker. The compounds exhibited a marked specificity for recombinant TRPM3 and blocked PregS-induced [Ca(2+)]i signals in freshly isolated DRG neurones. CONCLUSION AND IMPLICATIONS: The data indicate that citrus fruit flavonoids are potent and selective blockers of TRPM3. Their potencies ranged from upper nanomolar to lower micromolar concentrations. Since physiological functions of TRPM3 channels are still poorly defined, the development and validation of potent and selective blockers is expected to contribute to clarifying the role of TRPM3 in vivo. Considering the involvement of TRPM3 in nociception, TRPM3 blockers may represent a novel concept for analgesic treatment.